Macquarie bullish on Suven Pharma, Divi's Labs, Bluejet and Syngene
Macquarie said that the sector is currently at a turning point, driven by increased pharmaceutical outsourcing due to drug pricing pressures and geopolitical factors, prompting a global restructuring of the pharmaceutical supply (...)
Site référencé: The Economic Times
The Economic Times
IDFC First Bank allots Rs 4,876 crore worth preference shares to Warburg Pincus affiliate
1er/08/2025
Nuvama shares sink 6.5% in 2 days amid tax raids tied to Jane Street probe
1er/08/2025
Tariff woes temporary, India’s equity story still intact : Seshadri Sen
1er/08/2025
Chalet Hotels shares rally 8% after Q1 net profit surges 236% YoY
1er/08/2025
